Linh Hoang, M.D., Ph.D., is CEO of Weavr Health and Chairman of the Board of Directors. Prior to Weavr, Linh served as Vice President and General Manager of Reproductive Health Diagnostics at PerkinElmer. He has also held numerous leadership roles at Thermo Fisher Scientific, including General Manager of the clinical controls and standards business and Director for Life Technologies’ personalized medicine initiatives. Linh received his medical and doctoral degrees from the University of Pennsylvania and holds a bachelor’s in biochemistry from the University of Florida.

Christine Griggs is Senior Director of Finance for Weavr Health. Prior to Weavr, Christine was Financial Planning and Analysis Manager for TeraDiode, a Panasonic company. Christine has also held senior finance and accounting positions at Nova Ventures Group, T2 Biosystems and CHiL Semiconductor. Christine previously served in the United States Army Reserves. She holds a graduate degree in finance from Southern New Hampshire University and a bachelor’s in accounting from Franklin Pierce College.

Wendy Harman is Vice President of Product for Weavr Health. Wendy has extensive experience in developing new products, delivering commercial strategies and leading global brands. Prior to Weavr, Wendy was Vice President of Marketing, U.S. for Biofrontera, a biopharmaceutical company specializing in dermatological drugs. She has also held positions as Senior Director of New Product Planning at Alkermes, Director of Specialty GI Marketing for Internal Medicine/Oncology at Shire and Global Digital Marketing Lead for ImmunoDiagnostics at Thermo Fisher Scientific. Wendy earned a bachelor’s in biology from the Massachusetts Institute of Technology.

Mel Hernandez is Vice President of Business Development at Weavr Health. With more than 15 years of experience growing revenue in the biotechnology and pharmaceutical space, Mel was previously Senior Director of Business Development for ReadCoor, a spinout of George Church’s laboratory that was acquired by 10x Genomics. Prior to ReadCoor he was Business Development Manager for WuXi NextCODE, Senior Business Development Manager for Swift Biosciences and held various sales and business development roles at Thermo Fisher Scientific. Mel started his career managing the molecular biology lab at Harvard T.H. Chan School of Public Health. He earned a bachelor’s in biology from Syracuse University.

Ray Parvin is Vice President of Operations at Weavr Health. An accomplished leader with more than 20 years of experience in operations and finance, Ray previously served as Vice President and General Manager for Precision Coating Company. He has also held roles in operations and manufacturing management for Vicor Corporation and Smith & Nephew Endoscopy. He was previously a squad leader in the United States Marine Corps. Ray participated in the Small Business Investor Alliance (SBIA) executive development program at The Ohio State University Fisher College of Business and holds a master’s in business administration from Merrimack College.

Jingzi Sherman, M.D., C.C.R.A. is Vice President of Research and Development, Clinical for Weavr Health. She has more than 10 years of experience in IVD assay development, validation, health authority submission and post-market medical affairs. Prior to Weavr, Jingzi was Medical Director for Medical and Scientific Affairs and Global Medical and Scientific Affairs at Nova Biomedical. She previously held leadership roles in medical and scientific affairs at PerkinElmer and Roche Diagnostics. Jingzi received a medical degree from Shanghai Medical University and a master’s from the University of California, Davis. She is a Certified Clinical Research Associate and member of ACRP and AACC.

Rebecca Legare is the Vice President of Global Quality and Regulatory for Weavr Health. With more than 20 years of experience in the medical device industry, Rebecca has extensive quality and regulatory knowledge in medical device and in vitro diagnostics. Before joining Weavr, she served as Global Senior Director, Quality & Regulatory for COVID Programs and, prior to that, Global Director, R&D Quality and QMS Simplification, at PerkinElmer. Rebecca was previously a Senior Principal Consultant/Account Director for Regulatory and Quality (R&Q) Solutions and has also served in senior quality roles at Insulet Corporation and Boston Scientific. Rebecca earned a Bachelor’s in neuroscience from Smith College and a Master’s degree from the National Graduate School of Quality Management. She is a Six Sigma Black Belt, Certified Biomedical Auditor and a Firefighter/First Responder.